![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 207/16 | |
C07D 405/12 | |||
C07D 493/04 | |||
C07F 9/572 | |||
A61K 31/40 | |||
A61K 31/4035 | |||
A61P 35/00 |
(11) | Number of the document | 2825528 |
(13) | Kind of document | T |
(96) | European patent application number | 13708466.1 |
Date of filing the European patent application | 2013-03-12 | |
(97) | Date of publication of the European application | 2015-01-21 |
(45) | Date of publication and mention of the grant of the patent | 2017-05-24 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/054920 |
Date | 2013-03-12 |
(87) | Number | WO 2013/135648 |
Date | 2013-09-19 |
(30) | Number | Date | Country code |
201261611200 P | 2012-03-15 | US |
(72) |
FISHLOCK, Daniel, CH
BARTKOVITZ, David Joseph, US
CHU, Xin-Jie, CN
VU, Binh Thanh, US
ZHAO, Chunlin, CN
|
(73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(54) | SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES |
SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES |